Product Information
8HR ARTHRITIS PAIN ER 650 MG is a generic product labeled by AmerisourceBergen, priced at $0.0631 per EA under NDC 46122062978. Its NADAC has been published 295 times since Feb 10, 2021.
FDA first approved this application on Apr 16, 2019.
Strength
650 mg/1
Manufacturer
AmerisourceBergenNDC
46122062978
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ACETAMINOPHENApproval Type
Generic (ANDA)
FDA Application
ANDA211544FDA Approved
4/16/2019
On Market Since
1/13/2020
Price Statistics
The NADAC for 8HR ARTHRITIS PAIN ER 650 MG has been published 295 times since Feb 10, 2021, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0631 per EA |
|---|---|
| All-time high | $0.0759 (Mar 15, 2023) |
| All-time low | $0.0593 (Apr 21, 2021) |
| 52-week high | $0.0686 |
| 52-week low | $0.0629 |
| Median price | $0.0679 |
| Average price | $0.0671 |
| Largest weekly change | +16.2% (Feb 22, 2023) |
| Weeks tracked | 295 |
| Tracking since | Feb 10, 2021 |
Generic Alternatives
The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 5% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
AmerisourceBergen manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Acetaminophen market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of 8HR ARTHRITIS PAIN ER 650 MG?
The current National Average Drug Acquisition Cost (NADAC) for 8HR ARTHRITIS PAIN ER 650 MG, manufactured by AmerisourceBergen, is $0.0631 per EA (NDC 46122062978), effective Sep 30, 2026.
How has the price of 8HR ARTHRITIS PAIN ER 650 MG changed over time?
Over the history we have for it, the NADAC for 8HR ARTHRITIS PAIN ER 650 MG has held within roughly two percent of its current level. It has been tracked across 295 weekly CMS publications since Feb 10, 2021.
What are the highest and lowest recorded NADAC prices for 8HR ARTHRITIS PAIN ER 650 MG?
Since Feb 10, 2021, the NADAC for 8HR ARTHRITIS PAIN ER 650 MG has ranged from a low of $0.0593 (Apr 21, 2021) to a high of $0.0759 (Mar 15, 2023), with a median of $0.0679 per EA.
Are there cheaper alternatives to 8HR ARTHRITIS PAIN ER 650 MG?
Yes. 7 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, QC ARTHRITIS PAIN ER 650 MG, is $0.0599 per EA — about 5% below 8HR ARTHRITIS PAIN ER 650 MG.
Who manufactures 8HR ARTHRITIS PAIN ER 650 MG?
8HR ARTHRITIS PAIN ER 650 MG (NDC 46122062978) is labeled by AmerisourceBergen, and CMS classifies it as a generic product.